Position in AZN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$330,368,152
New position
Shares Held
1,675,125
first reported quarter
Ownership
0.108%
of shares outstanding
% of Portfolio
9.25%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Evelyn Partners Investment Management LLP holds $374,837,460 across 12 Drug Manufacturers - General names. AZN ranks #1 (88.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
1,675,125 | $330,368,152 | |
| 2 | JNJ |
Johnson & Johnson
|
135,066 | $33,015,533 | |
| 3 | LLY |
ELI LILLY & Co
|
7,228 | $6,648,097 | |
| 4 | MRK |
Merck & Co., Inc.
|
13,690 | $1,646,770 | |
| 5 | PFE |
Pfizer Inc
|
55,712 | $1,564,392 | |
| 6 | ABBV |
AbbVie Inc.
|
4,210 | $915,632 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,339 | $323,810 | |
| 8 | NVS |
Novartis AG
|
700 | $106,925 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $330,368,152 | 1,675,125 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||